Literature DB >> 19903738

Bacterial display enables efficient and quantitative peptide affinity maturation.

Sophia A Kenrick1, Patrick S Daugherty.   

Abstract

A quantitative screening method was developed to enable isolation and affinity maturation of peptide ligands specific for a given target from peptide libraries displayed on the outer surface of Escherichia coli using multi-parameter flow cytometry. From a large, random 15-mer peptide library, screening identified a core motif of W-E/D-W-E/D that conferred binding to vascular endothelial growth factor (VEGF). One cycle of affinity maturation resulted in the identification of several families of VEGF-binding peptides having distinct consensus sequences, from which a preferred disulfide constraint emerged. In the second affinity maturation cycle, high affinity peptides were favored by the addition of a decoy protein that bound an adjacent epitope on the display scaffold. The decoy apparently reduced rebinding or avidity effects, and the resulting peptides exhibited consensus at 12 of 19 amino acid positions. Peptides identified and affinity matured using bacterial display were remarkably similar to the best affinity matured using phage display and exhibited comparable dissociation constants (within 2-fold; K(D) = 4.7 x 10(-7) M). Screening of bacterial-displayed peptide libraries using cytometry enabled optimization of screening conditions to favor affinity and specificity and rapid clonal characterization. Bacterial display thus provides a new quantitative tool for the discovery and evolutionary optimization of protein-specific peptide ligands.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19903738      PMCID: PMC2791049          DOI: 10.1093/protein/gzp065

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  33 in total

1.  High affinity RNase S-peptide variants obtained by phage display have a novel "hot-spot" of binding energy.

Authors:  J J Dwyer; M A Dwyer; A A Kossiakoff
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

Review 2.  Therapeutic peptides.

Authors:  Samantha Lien; Henry B Lowman
Journal:  Trends Biotechnol       Date:  2003-12       Impact factor: 19.536

3.  Using bio-panning of FLITRX peptide libraries displayed on E. coli cell surface to study protein-protein interactions.

Authors:  Zhijian Lu; Edward R LaVallie; John M McCoy
Journal:  Methods Mol Biol       Date:  2003

4.  DNA display for in vitro selection of diverse peptide libraries.

Authors:  Masato Yonezawa; Nobuhide Doi; Yuko Kawahashi; Toru Higashinakagawa; Hiroshi Yanagawa
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

5.  Complex spatial distribution and dynamics of an abundant Escherichia coli outer membrane protein, LamB.

Authors:  Karine A Gibbs; Daniel D Isaac; Jun Xu; Roger W Hendrix; Thomas J Silhavy; Julie A Theriot
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

6.  Synthetic peptides in the form of dendrimers become resistant to protease activity.

Authors:  Luisa Bracci; Chiara Falciani; Barbara Lelli; Luisa Lozzi; Ylenia Runci; Alessandro Pini; Maria Graziella De Montis; Alessandro Tagliamonte; Paolo Neri
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

7.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

8.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

9.  Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.

Authors:  Borlan Pan; Bing Li; Stephen J Russell; Jeffrey Y K Tom; Andrea G Cochran; Wayne J Fairbrother
Journal:  J Mol Biol       Date:  2002-02-22       Impact factor: 5.469

10.  Epitope mapping of antibodies using bacterial surface display.

Authors:  Johan Rockberg; John Löfblom; Barbara Hjelm; Mathias Uhlén; Stefan Ståhl
Journal:  Nat Methods       Date:  2008-11-23       Impact factor: 28.547

View more
  22 in total

1.  Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources.

Authors:  Benjamin J Tillotson; Iñigo F de Larrinoa; Colin A Skinner; Derek M Klavas; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2012-10-28       Impact factor: 1.650

2.  Protease-resistant peptide ligands from a knottin scaffold library.

Authors:  Jennifer A Getz; Jeffrey J Rice; Patrick S Daugherty
Journal:  ACS Chem Biol       Date:  2011-06-16       Impact factor: 5.100

3.  Characterization of antibody specificities associated with preeclampsia.

Authors:  Serra E Elliott; Nicholas F Parchim; Chen Liu; Yang Xia; Rodney E Kellems; Alex R Soffici; Patrick S Daugherty
Journal:  Hypertension       Date:  2014-01-20       Impact factor: 10.190

4.  A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells.

Authors:  Melissa A Gray; Ran N Tao; Sandra M DePorter; David A Spiegel; Brian R McNaughton
Journal:  Chembiochem       Date:  2015-12-10       Impact factor: 3.164

Review 5.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

6.  Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes - relevance for vaccine design.

Authors:  Galina F Denisova; Dimitri A Denisov; Jonathan L Bramson
Journal:  Immunome Res       Date:  2010-11-03

7.  Screening of peptide libraries against protective antigen of Bacillus anthracis in a disposable microfluidic cartridge.

Authors:  Joshua M Kogot; Yanting Zhang; Stephen J Moore; Paul Pagano; Dimitra N Stratis-Cullum; David Chang-Yen; Marek Turewicz; Paul M Pellegrino; Andre de Fusco; H Tom Soh; Nancy E Stagliano
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

8.  Is nanomedicine still promising?

Authors:  Pubudu M Peiris; Efstathios Karathanasis
Journal:  Oncotarget       Date:  2011-06

9.  Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery.

Authors:  Andreas Gratz; Andre Bollacke; Sara Stephan; Christian Nienberg; Marc Le Borgne; Claudia Götz; Joachim Jose
Journal:  Microb Cell Fact       Date:  2015-06-03       Impact factor: 5.328

10.  Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms.

Authors:  Michael R Kierny; Thomas D Cunningham; Brian K Kay
Journal:  Nano Rev       Date:  2012-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.